Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A pilot trial of intravenous pamidronate for chronic low back pain.

Pappagallo M, Breuer B, Lin HM, Moberly JB, Tai J, Noto C, Sanchez A, Manfredi PL.

Pain. 2014 Jan;155(1):108-17. doi: 10.1016/j.pain.2013.09.016. Epub 2013 Sep 21.

2.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
3.

Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial.

Cecchetti S, Pereira B, Roche A, Deschaumes C, Abdi D, Coudeyre E, Dubost JJ, Mathieu S, Malochet-Guinamand S, Tournadre A, Couderc M, Vayssade M, Daron C, Soubrier M.

Trials. 2014 Apr 9;15:117. doi: 10.1186/1745-6215-15-117.

4.

Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.

Armingeat T, Brondino R, Pham T, Legré V, Lafforgue P.

Osteoporos Int. 2006;17(11):1659-65. Epub 2006 Aug 8.

PMID:
16896508
5.

Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging.

Koivisto K, Kyllönen E, Haapea M, Niinimäki J, Sundqvist K, Pehkonen T, Seitsalo S, Tervonen O, Karppinen J.

BMC Musculoskelet Disord. 2014 Mar 4;15:64. doi: 10.1186/1471-2474-15-64.

6.

Efficacy and safety of duloxetine in patients with chronic low back pain.

Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M.

Spine (Phila Pa 1976). 2010 Jun 1;35(13):E578-85. doi: 10.1097/BRS.0b013e3181d3cef6.

PMID:
20461028
7.

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.

Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.

Transpl Int. 2009 Feb;22(2):198-206. doi: 10.1111/j.1432-2277.2008.00763.x. Epub 2008 Sep 15. Erratum in: Transpl Int. 2009 Jun;22(6):679. Torne, Santiago [corrected to Tome, Santiago].

8.

High-dose intravenous pamidronate for metastatic bone pain.

Purohit OP, Anthony C, Radstone CR, Owen J, Coleman RE.

Br J Cancer. 1994 Sep;70(3):554-8.

9.

Bisphosphonates for breast cancer.

Pavlakis N, Stockler M.

Cochrane Database Syst Rev. 2002;(1):CD003474. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003474.

PMID:
11869664
10.

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.

Coats TL, Borenstein DG, Nangia NK, Brown MT.

Clin Ther. 2004 Aug;26(8):1249-60.

PMID:
15476906
11.
12.

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.

Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO.

J Clin Oncol. 2003 Dec 1;21(23):4277-84. Epub 2003 Oct 27.

PMID:
14581438
13.

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.

Kivitz AJ, Gimbel JS, Bramson C, Nemeth MA, Keller DS, Brown MT, West CR, Verburg KM.

Pain. 2013 Jul;154(7):1009-21. doi: 10.1016/j.pain.2013.03.006. Epub 2013 Mar 14.

PMID:
23628600
14.

Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.

Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K.

JAMA. 2010 Jul 7;304(1):45-52. doi: 10.1001/jama.2010.893.

PMID:
20606148
15.

Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.

Cvitkovic F, Armand JP, Tubiana-Hulin M, Rossi JF, Warrell RP Jr.

Cancer J. 2006 Jan-Feb;12(1):47-53.

PMID:
16613662
16.

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.

Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ.

Cancer. 2000 Mar 1;88(5):1082-90.

PMID:
10699899
17.

Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).

Kraj M, Pogłód R, Maj S, Pawlikowski J, Sokołowska U, Szczepanik J.

Acta Pol Pharm. 2002 Nov-Dec;59(6):478-82.

18.

Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial.

Koeberle D, Bacchus L, Thuerlimann B, Senn HJ.

Support Care Cancer. 1999 Jan;7(1):21-7.

PMID:
9926970
19.
20.

[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].

Dong M, Feng FY, Zhang Y, Xie GR, Wang YJ, Liu JW, Song ST, Zhou QH, Ren J, Jiao SC, Li J, Wang XW, Chen Q, Wang ZH, Xu N, Feng JF.

Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):215-20. Chinese.

PMID:
18756940
Items per page

Supplemental Content

Write to the Help Desk